The KD may be especially beneficial in women with obesity and endometriosis, who often present with an altered metabolic phenotype with insulin resistance, chronic inflammation, and increased peripheral aromatization of androgens into estrogens in adipose tissue by aromatases. The gene discussed is CYP19A1; the disease is endometriosis.